Dr. Gregory Riely on Using Next-Generation Sequencing to Identify Lung Cancer Mutations
December 3rd 2015
Gregory Riely, MD Medical Oncologist, Vice Chair, Clinical Trials Office, Department of Medicine, Memorial Sloan Kettering, discusses the benefits and challenges of using next-generation sequencing to identify mutations in lung cancer.